The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Week of July 3:
Akcea Therapeutics - Cambridge, Mass., 9.6 million shares, priced $12-$14, managed by Cowen and Company/StifelWells/Fargo Securities. Proposed Nasdaq symbol AKCA. Business: Biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.
This content appears as provided to The Globe by the originating wire service. It has not been edited by Globe staff.